BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37589282)

  • 1. Salivary Gland Neoplasms With a Unique Trabecular Histology and MAML2 Translocation : A Trabecular Variant of a Mucoepidermoid Carcinoma.
    Ahn B; Choi SH; Kim D; Kim D; Cho KJ
    Am J Surg Pathol; 2023 Oct; 47(10):1085-1095. PubMed ID: 37589282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours.
    Bishop JA; Thompson LDR; Siegele B; Gagan J; Mansour M; Chernock RD; Rooper LM
    Histopathology; 2023 Jan; 82(2):305-313. PubMed ID: 36208053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
    Saade RE; Bell D; Garcia J; Roberts D; Weber R
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
    Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
    Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
    Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
    Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAML2 Rearrangements in Variant Forms of Mucoepidermoid Carcinoma: Ancillary Diagnostic Testing for the Ciliated and Warthin-like Variants.
    Bishop JA; Cowan ML; Shum CH; Westra WH
    Am J Surg Pathol; 2018 Jan; 42(1):130-136. PubMed ID: 28877061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: Systematic review and meta-analysis.
    Pérez-de-Oliveira ME; Wagner VP; Araújo ALD; Martins MD; Santos-Silva AR; Bingle L; Vargas PA
    J Oral Pathol Med; 2020 May; 49(5):386-394. PubMed ID: 31661572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.
    Ge Y; Lin X; He J; Chen W; Lin D; Zheng Y; Yang L; Xu F; Li Z
    Diagn Pathol; 2024 Jan; 19(1):15. PubMed ID: 38243319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
    Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
    Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.
    Cipriani NA; Lusardi JJ; McElherne J; Pearson AT; Olivas AD; Fitzpatrick C; Lingen MW; Blair EA
    Am J Surg Pathol; 2019 Jul; 43(7):885-897. PubMed ID: 31021855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
    Seethala RR; Dacic S; Cieply K; Kelly LM; Nikiforova MN
    Am J Surg Pathol; 2010 Aug; 34(8):1106-21. PubMed ID: 20588178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Mucoepidermoid Carcinoma of the Lacrimal Apparatus.
    Sun H; Cai R; Zhai C; Song W; Sun J; Bi Y
    Am J Ophthalmol; 2022 Jul; 239():170-179. PubMed ID: 35288069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
    Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
    Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old Boy.
    Han SH; O'Toole TR; Meyer RG; Geiersbach KB; Islam MN; Cheng L; Lai J
    Anticancer Res; 2023 Feb; 43(2):939-942. PubMed ID: 36697075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
    Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
    Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.